Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 2
1(16.7%)
6Total
N/A(5)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04719663Not ApplicableCompleted

The Modulatory Role of Communicated Treatment Rationale on Treatment Expectation Effects in Depression.

Role: collaborator

NCT01483339Not ApplicableCompleted

Metacognitive Therapy for Patients With Obsessive-Compulsive Disorder

Role: collaborator

NCT01484418Not ApplicableCompleted

Exposure-based Treatment for Avoidant Back Pain Patients

Role: collaborator

NCT03157622Not ApplicableCompleted

Single-Case Study on Therapeutic Change in Chronic Low Back Pain

Role: collaborator

NCT00596765Not ApplicableCompleted

Neuropsychological Cognitive Behavioral Therapy for Patients With Acquired Brain Injury

Role: collaborator

NCT00769561Phase 2Completed

Biofeedback-Based Cognitive Behavioral Treatment for Temporomandibular Disorders

Role: collaborator

All 6 trials loaded